SG11202110773RA - Compositions and methods for analyte detection using bioluminescence - Google Patents

Compositions and methods for analyte detection using bioluminescence

Info

Publication number
SG11202110773RA
SG11202110773RA SG11202110773RA SG11202110773RA SG11202110773RA SG 11202110773R A SG11202110773R A SG 11202110773RA SG 11202110773R A SG11202110773R A SG 11202110773RA SG 11202110773R A SG11202110773R A SG 11202110773RA SG 11202110773R A SG11202110773R A SG 11202110773RA
Authority
SG
Singapore
Prior art keywords
bioluminescence
compositions
methods
analyte detection
analyte
Prior art date
Application number
SG11202110773RA
Inventor
Thomas Kirkland
Melanie Dart
Zhiyang Zeng
Thomas Smith
Keith Wood
Thomas Machleidt
Emily Jost
Virginia Kincaid
Hui Wang
Wenhui Zhou
Lance Encell
Mary Hall
Robin Hurst
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of SG11202110773RA publication Critical patent/SG11202110773RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/103—Nucleic acid detection characterized by the use of physical, structural and functional properties luminescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
SG11202110773RA 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence SG11202110773RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962832052P 2019-04-10 2019-04-10
PCT/US2020/027711 WO2020210658A1 (en) 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence

Publications (1)

Publication Number Publication Date
SG11202110773RA true SG11202110773RA (en) 2021-10-28

Family

ID=72751365

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110773RA SG11202110773RA (en) 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence

Country Status (11)

Country Link
US (1) US20200386748A1 (en)
EP (1) EP3953374A4 (en)
JP (1) JP2022526013A (en)
KR (1) KR20220007058A (en)
CN (1) CN113891895A (en)
AU (1) AU2020272037A1 (en)
BR (1) BR112021020354A2 (en)
CA (1) CA3135195A1 (en)
IL (1) IL287261A (en)
SG (1) SG11202110773RA (en)
WO (1) WO2020210658A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023503653A (en) * 2019-11-27 2023-01-31 プロメガ コーポレイション Multimolecular luciferase peptides and polypeptides
WO2023028175A1 (en) * 2021-08-24 2023-03-02 Kaya17 Inc. System and method for detecting presence of a target bioparticle in a sample via a vertical flow assay
CN113786873B (en) * 2021-08-31 2022-09-23 广西横县张一元饮品有限公司 Test tube for food safety detection
CN114231401B (en) * 2022-02-21 2022-05-03 北京芯迈微生物技术有限公司 Nucleic acid detection kit and detection method
WO2023200703A1 (en) * 2022-04-15 2023-10-19 Siemens Healthcare Diagnostics Inc. Creatinine lateral flow assay devices and methods of production and use thereof
GB2619059A (en) * 2022-05-26 2023-11-29 Univ Leeds Innovations Ltd Split reporter complex
CN116218907A (en) * 2023-02-20 2023-06-06 复旦大学附属中山医院 Enterovirus infectious clone with HiBiT novel reporter gene, construction method and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423290A (en) * 1966-08-03 1969-01-21 Nasa Lyophilized reaction mixtures
US6045254A (en) * 1996-12-26 2000-04-04 M.L.I.S. Projects Ltd. Container having two or more compartments
US7118878B1 (en) * 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
AU2003300008B2 (en) * 2002-12-23 2007-04-05 Promega Corporation Improved luciferase-based assays
US7829347B2 (en) * 2005-08-31 2010-11-09 Kimberly-Clark Worldwide, Inc. Diagnostic test kits with improved detection accuracy
EP2215450B1 (en) * 2006-02-21 2013-07-31 Nexus DX, Inc. Methods and compositions for analyte detection
US10067149B2 (en) * 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US9797889B2 (en) * 2013-03-15 2017-10-24 Promega Corporation Activation of bioluminescence by structural complementation
WO2016040835A1 (en) * 2014-09-12 2016-03-17 Promega Corporation Internal protein tags
EP3254113A4 (en) * 2015-02-05 2018-06-27 Promega Corporation Luciferase-based thermal shift assays
WO2017143323A1 (en) * 2016-02-19 2017-08-24 Insight Instruments, Inc. Assay systems for point of care detection of ocular analytes
WO2017189751A1 (en) * 2016-04-26 2017-11-02 The University Of Utah Research Foundation Target-binding activated split reporter systems for analyte detection and related components and methods
JP6990369B2 (en) * 2017-05-19 2022-02-03 国立大学法人 熊本大学 Evaluation system for therapeutic agents for hereditary renal disease Alport syndrome

Also Published As

Publication number Publication date
BR112021020354A2 (en) 2021-12-14
US20200386748A1 (en) 2020-12-10
CN113891895A (en) 2022-01-04
AU2020272037A1 (en) 2021-12-02
KR20220007058A (en) 2022-01-18
EP3953374A4 (en) 2023-06-07
CA3135195A1 (en) 2020-10-15
JP2022526013A (en) 2022-05-20
IL287261A (en) 2021-12-01
WO2020210658A1 (en) 2020-10-15
EP3953374A1 (en) 2022-02-16

Similar Documents

Publication Publication Date Title
IL287261A (en) Compositions and methods for analyte detection using bioluminescence
IL265396A (en) Methods and compositions for detecting analytes
EP3258270A4 (en) Cardiac troponin i ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
EP4077722C0 (en) Methods of detecting an analyte
EP3798616A4 (en) Chemical luminescence analysis and measurement method, system using same, and kit
EP3879261A4 (en) Potentiometric biosensor and detection method
EP4077717C0 (en) Method of detecting an analyte
EP3415912A4 (en) Analyte detection method and reagent kit for detecting analyte
GB202007911D0 (en) Analyte detection method
EP3473715A4 (en) Catalase inhibitor and method for measuring analyte using catalase inhibitor
IL288081A (en) Rapid aneuploidy detection
EP3922992A4 (en) Kit for measuring analyte and method for measuring analyte
IL291075A (en) Compositions and methods for detecting and depleting sample interferences
EP3460454A4 (en) Biosensor and method for analyzing specimen by using same
EP3849938A4 (en) Methods and compositions for high sensitivity sequencing in complex samples
IL290969A (en) Equi-probability defect detection
EP3767294A4 (en) Reagent kit, measurement kit, and measurement method
EP3722811A4 (en) Kit and method for quantitative detecting hbsag
EP3741857A4 (en) Detergent for corneum-derived stains, and method for evaluating ability to degrade corneum-derived stains
GB201902630D0 (en) Analyte detection method
EP3908290A4 (en) Compositions and methods for detecting cardiotoxicity
EP3919511A4 (en) Reagent kit, measurement kit, and measurement method
EP3919510A4 (en) Reagent kit, measurement kit and measurement method
EP3832308A4 (en) Reagent kit for detecting biofilm and method for detecting biofilm
EP3764878A4 (en) Composition and methods for sensitive molecular analysis